SRP-9003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SRP-9003, covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency) [Phase 1]